A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naïve people with type 2 diabetes: A randomized, controlled trial

  1. Heise, T.
  2. Tack, C.J.
  3. Cuddihy, R.
  4. Davidson, J.
  5. Gouet, D.
  6. Liebl, A.
  7. Romero, E.
  8. Mersebach, H.
  9. Dykiel, P.
  10. Jorde, R.
Revue:
Diabetes Care

ISSN: 0149-5992,  1935-5548

Année de publication: 2011

Volumen: 34

Número: 3

Pages: 669-674

Type: Article

DOI: 10.2337/DC10-1905 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus